Regular aspirin may help lower risk of colorectal cancer, especially in individuals with less healthy lifestyles, according to a study led by Harvard-affiliated researchers.
The study analyzed data from over 100,000 participants, finding those who regularly took aspirin had a lower 10-year cumulative incidence of colorectal cancer compared to non-regular users.
The U.S. Preventive Services Task Force previously recommended aspirin for colorectal cancer prevention but withdrew due to concerns about gastrointestinal bleeding.
Research aims to personalize prevention strategies by identifying individuals who would benefit most from regular aspirin use.
Collection
[
|
...
]